• Return to Headlines

Esperion Therape Shares Down 39.7% Since SmarTrend's Sell Call (ESPR)

By James Quinn

SmarTrend identified a Downtrend for Esperion Therape (NASDAQ:ESPR) on April 25th, 2018 at $69.96. In approximately 3 weeks, Esperion Therape has returned 39.74% as of today's recent price of $42.16.

In the past 52 weeks, Esperion Therape share prices have been bracketed by a low of $9.40 and a high of $82.68 and are now at $42.16, 349% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 5.3% while the 50-day MA has declined 0.6%.

Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Esperion Therape.

Log in and add Esperion Therape (ESPR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights esperion therape

Ticker(s): ESPR